CII to work with Serum Institute of India to expand vaccination across small towns and rural areas
As part of the pan-India vaccine-demand aggregation exercise, CII undertook a survey with response from over 3,000 companies in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
After suspending EUA request, Brazil now shelves import authorisation of Covaxin
According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa, its Collegiate Board recently took a…
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC
Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15…
Biocon Biologics and Adagio Therapeutics to develop antibody treatment for COVID-19
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging markets
BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
Only marginal difference in purchase price of Covishield and Covaxin for Centre: MoS Health
The Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries…
EU begins real-time review of Sanofi-GSK COVID-19 vaccine
The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and…
Centre allows research on AYUSH Medicines to curb COVID-19
States/UTs licensing authorities have been requested to expedite the process of the licensing/approval of applications for the…
CDSCO grants permission to three private COVID-19 vaccines for restricted use in emergency situation…
The information was given today by Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers, in a written reply in the Lok…
Chugai Pharma obtains regulatory approval for anti-SARS-CoV-2 monoclonal antibody Ronapreve
The special approval for emergency under article 14-3 of the Pharmaceuticals and Medical Devices Act was applied to this approval
Centre provides over 42 crore vaccine doses to states and UTs
Over 2.11 crore balance and unutilised doses still available with states and Union Territories (UTs), and private hospitals
Centre to buy Covishield and Covaxin at revised rates
The price of each dose of Covishield amounts to Rs 215.25, and Covaxin Rs 225.75, including taxes
US FDA to review full approval of Pfizer/BioNTech’s COVID-19 vaccine by January
The target action date does not mean the approval will not happen before January, the US Food and Drug Administration's Acting…
Celltrion’s monoclonal antibody treatment for COVID-19 works against Delta variant: Study
Regdanvimab (CT-P59) also retained its neutralisation potency against the Lambda variant (C.37, first identified in Peru) using a…
Heat-tolerant COVID-19 vaccine from IISc effective against all major SARS-CoV-2 variants: Study
The research, published in the ACS Infectious Diseases journal on Thursday, showed that vaccine formulations by IISc-incubated…
Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…
Heparin may cut risk of severe disease and death in COVID-19 patients: Study
The study showed that therapeutic heparin is beneficial in moderately ill hospitalised patients but not in severely ill ICU…
COVID-19 vaccine market set to reach $19.5 bn by 2026: GlobalData
COVID-19 vaccines based on mRNA technology dominate the 7MM in 2021 with a market share of 95.4 per cent and $9.5 billion in sales…
US claims it is unable to send COVID vaccines as India needs to review its legal provisions
We are ready to ship those vaccines expeditiously when we have a green light from the Government of India, said State Department…
SII to commence manufacturing of Sputnik COVID-19 vaccine in September
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year